Skip to main content
Clinical Trials/JPRN-UMIN000009082
JPRN-UMIN000009082
Completed
Phase 1

Efficacy of recombinant human soluble thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis. - Efficasy of recombinant thrombomodulin for AE-IPF.

Toho university0 sites10 target enrollmentOctober 10, 2012

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
acute exacerbation of idiopathic pulmonary fibrosis
Sponsor
Toho university
Enrollment
10
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 10, 2012
End Date
August 31, 2014
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\)A person having an infection of apparent activity 2\)Those who have apparent congestive heart failure. 3\) Those who have apneumothorax 4\) Those who have athma 5\) Those who have deep vein thrombosis to be treated. 6\) Who has the possibility of pulmonary arterial thromboembolism 7\) A person who has circulatory failure, renal failure, liver failure 8\) Those who have intracranial hemorrhage, pulmonary hemorrhage, gastrointestinal bleeding 9\)A person with a history of hypersensitivity to components of the thrombomodulin 10\) Women who may be pregnant or are pregnant

Outcomes

Primary Outcomes

Not specified

Similar Trials